Related Experiment Video

Updated: Mar 5, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.7K

Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions

Mohammad Ahsanul Akbar1, David Nardo1, Mong-Jen Chen1

  • 1Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.

Molecular Medicine (Cambridge, Mass.)
|March 24, 2017
PubMed

Insights

Alpha-1 antitrypsin (AAT) inhibits osteoclast formation and function, offering potential therapeutic benefits for osteoporosis. This study reveals new mechanisms by which AAT protects bone tissue.

Area of Science:

  • Biochemistry
  • Immunology
  • Bone Biology

Background:

  • Osteoporosis affects over 200 million people globally, representing a significant public health concern.
  • Alpha-1 antitrypsin (AAT), a protein with anti-inflammatory properties, has previously shown promise in mitigating bone loss.
  • The precise mechanisms by which AAT exerts its protective effects on bone tissue remain largely unelucidated.

Purpose of the Study:

  • To investigate the effects of alpha-1 antitrypsin (AAT) on osteoclast formation and function in vitro.
  • To elucidate the molecular mechanisms underlying AAT's potential therapeutic effects in osteoporosis.

Main Methods:

  • Osteoclast differentiation was induced using RANKL (receptor activator of nuclear factor κB ligand) and M-CSF (macrophage colony-stimulating factor).
  • AAT's effects on osteoclast formation, gene expression (RANK, TNF-α, CD9, DC-STAMP), and mineral resorption were assessed.
  • Experiments utilized mouse bone marrow-derived macrophages and the RAW 264.7 cell line.

Main Results:

  • AAT demonstrated dose-dependent inhibition of RANKL-induced osteoclast formation.
  • AAT suppressed M-CSF-induced RANK expression on osteoclast precursor cells.
  • AAT inhibited RANKL-induced TNF-α production, CD9 expression, DC-STAMP gene expression, and osteoclast-associated mineral resorption.

Conclusions:

  • AAT effectively inhibits osteoclast formation and function through multiple molecular pathways.
  • These findings reveal novel mechanisms for AAT's bone-protective effects.
  • AAT exhibits significant therapeutic potential for the treatment of osteoporosis.
Keywords:
Mineral resorptionOsteoclastogenesisOsteoporosisRANKc-Fos

More Related Videos

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.6K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K